University of Cincinnati Start-up Company Opportunities - PowerPoint PPT Presentation

University of Cincinnati Start-up Company Opportunities NCET2/Global 1000 Conference March 19, 2014 Dorothy H. Air, PhD Associate Vice President Entrepreneurial Affairs & Tech Commercialization dorothy.air@uc.edu

University of Cincinnati Technology Commercialization • Technology Commercialization Accelerator – Newly launched one-stop resource for translating scientific breakthroughs into market opportunities – Provides: • Commercialization Gap Funding • Entrepreneurs-in-residence to evaluate and guide commercialization work • External Advisory Board to assist in opportunity assessment and connections to external resources • Intellectual Property functions aligned with commercialization potential

Opportunity Base Research Intensive University $227 Million Research Expenditures 2010 2011 2012 2013 Invention 82 106 123 98 Disclosures Patent 50 70 75 95 Applications Patents 16 11 20 17 Issued Start-up 7 3 6 2 Activity

Research and Innovation Strengths Partial list . . .  Nanotechnology  Water Quality Biotechnology  Sensors and Controls  Cybersecurity  Intelligent Autonomous  Imaging Systems  Tissue Engineering  Sustainable Urban  Medical Devices Engineering  Diagnostics and Therapeutics  Robotics  Cancer Biology  Microfluidics  Cardiovascular and Pulmonary  Microfilms Biology  Immunobiology  BioMEMS  Neuroscience  Semi Conductors  Molecular Genetics  Energy Systems  Environmental Health  Power & Propulsion  Gastrointestinal Biology  Industrial Design

SENSE Diagnostics, LLC • Company Summary: – Early stage start-up neurotechnology company developing a medical device for Sensor Evaluation of Neurologic Status in Emergencies (SENSE) in response to a large unmet market need. • Product: – A non-invasive radio frequency based device that detects sudden signal changes in brain status in seizures, hemorrhage, or increased brain swelling. • Competitive Advantages: – 1st non-invasive, continuous device monitor – Portability for use in field, OR, ED, patient room – Low cost and greater effectiveness than CT, EEG, BIS and MEG – Potential major health care savings through • Immediate change identification to mitigate disabling patient outcomes • Ease of use (no reliance on correct wire lead placement, ionizing radiation or highly-trained experts) • IP : pending US and EP applications • Funding Status: $170,000 University and NIH NIBIB Grants; Raising 1 st capital round

Gamma Dynamics • Company Summary: – Early stage start-up company focused on electrofluidics-based display products, with 4 platforms demonstrated and under development • Product: Electrofluidic display technology for various e-Paper applications such as – eBook readers. Also applications for store product labels and signs • Competitive Advantages – High brightness and optimal readability in direct sunlight. – Flexible, even rollable/foldable displays allowing large i-Pad type screen sizes to be stored with the pocket size of a smart phone. – Full color and video capabiklity. Since the displays – No backlighting with extremely low – no heavy batteries • Patent Status: 3 pending & 3 issued US patents, 2 allowed US applications • Funding : $3,043,165 federal & $043,165 non-federal funding; raising A round

Eccrine Systems, LLC • Company Summary: – Early stage start-up focused on technology for real-time capture and analysis of eccrine sweat via wearable sweat sensor – Strategic “vertical” business model for maximum horizontal positioning across markets with vertical segment preservation for maximum economic potential. • Product: Wearable microfluidics and flexible electronics sensor that enables the real-time capture, sensing, measurement, and wireless communication of biomolecules to smart phones and other reporting devices for monitoring status of multiple physical conditions. • Competitive Advantages: – Novel approach for measuring biomolecules – Applicable to 3 huge markets: elite performers, medical diagnostics, consumer lifestyle management. (Potential $2B global market) – Proof of concept, 4 platforms demonstrated, and prototype established – Low manufacturing Cost • IP: pending provisional and PCT applications • Funding Status: $850,000 in non-dilutive funding; Raising Seed-Round

OsteoDynamics, Inc. • Company Summary: – Start-up company developing diagnostic device that measures bone quality enabling better identification of patients at risk for osteoporosis- related fractures than is possible through bone mineral density measures. Prototype and clinical validation data completed. • Product: – A device and related software to measure Bone Shock Absorption energy in mild shock waves from normal activities (walking, foot tapping) • Competitive Advantages: – Significant health care savings through more effective determination of and treatment recommendations for osteoporosis related bone fractures – Low cost technology and easy patient access – Portability and ability to use in standard patient examining room • Patent Status: pending US application • Funding: $160,000 grant awards; $286,050 founders and convertible notes; Raising $1.4M to take through FDA approval

Contact OEATC Web Address: ht t p://ipo.uc.edu Available Techs: http://ipo.uc.edu/tech http://twitter.com /oeatc Twitter: Phone: (513) 558-6293 Dorothy H. Air, PhD Associate Vice President, Entrepreneurial Affairs and Technology Commercialization dorothy.air@uc.edu